Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Olema Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +4 vs. Q2 2025
- Shares held
- 68.3M
- −2.20M (−3.1%) vs. Q2 2025
- Total value
- $668.2M
- +$367.9M (+122.5%) vs. Q2 2025
- New holders
- 20
- 42 more added
- Sold out
- 16
- 36 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 2,525 | $24.7K | 0.00% | −5,479−68.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 2,000 | $19.6K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 1,707 | $16.0K | 0.01% | −8,293−82.9% | Reduced |
| GF Fund Management Co. Ltd. | 1,477 | $14.5K | 0.00% | +55+3.9% | Added |
| Amalgamated Bank | 1,411 | $14.0K | 0.00% | 00.0% | Unchanged |
| Versant Capital Management, Inc | 1,423 | $13.9K | 0.00% | +488+52.2% | Added |
| Quest Partners LLC | 898 | $8.79K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 838 | $8.20K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 717 | $7.02K | 0.00% | +1+0.1% | Added |
| Wolff Wiese Magana LLC | 600 | $5.87K | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 466 | $4.56K | 0.00% | +466 | New |
| Point72 Europe (London) LLP | 404 | $3.96K | 0.00% | +404 | New |
| UMA Financial Services, Inc. | 391 | $3.83K | 0.00% | +155+65.7% | Added |
| Optiver Holding B.V. | 236 | $2.31K | 0.00% | +236 | New |
| GAMMA Investing LLC | 231 | $2.26K | 0.00% | +231 | New |
| Rothschild Investment LLC | 225 | $2.20K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 224 | $2.00K | 0.00% | 00.0% | Unchanged |
| Parkside Financial Bank & Trust | 135 | $1.32K | 0.00% | 00.0% | Unchanged |
| True Wealth Design, LLC | 61 | $598 | 0.00% | +52+577.8% | Added |
| SBI Securities Co., Ltd. | 51 | $499 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 30 | $294 | 0.00% | −6,809−99.6% | Reduced |
| EverSource Wealth Advisors, LLC | 13 | $127 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 6 | $59 | 0.00% | +6 | Added |
| SRS Capital Advisors, Inc. | 5 | $49 | 0.00% | +5 | New |
| Huntington National Bank | 1 | $10 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 16 | $0 | 0.00% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −2,378,762−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −618,184−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −253,657−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −194,450−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −80,414−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −72,455−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −58,980−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −58,333−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −54,177−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −22,133−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −16,288−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −14,699−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −12,800−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| SWAN Capital LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| EP Wealth Advisors, LLC | – | – | – | – | Not filed |